Engaging Clinical Champions to Improve HPV Vaccination
2 other identifiers
interventional
47
1 country
2
Brief Summary
This trial will compare two ways to improve communication about HPV vaccination in primary care. The research team will work with primary care clinics. Some clinics will receive communication training from an outside expert. Other clinics will receive the same training from a vaccine champion from their healthcare system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2023
CompletedFirst Posted
Study publicly available on registry
February 21, 2023
CompletedStudy Start
First participant enrolled
March 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedMarch 9, 2026
July 1, 2025
2.3 years
February 10, 2023
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HPV vaccination (≥1 dose), 9-12 year olds
Proportion of unvaccinated children who initiate the HPV vaccine series between baseline and 12-month follow-up, among those who were ages 9-12 at baseline
from baseline to 12 months
Secondary Outcomes (1)
HPV vaccination (2 doses), 9-12 year olds
from baseline to 12 months
Study Arms (2)
Champion AAT
EXPERIMENTALStaff in clinics randomized to this arm will receive an intervention called Announcement Approach Training (AAT). This training is designed to improve communication about HPV vaccination. The training will be organized and delivered by vaccine champions from participating healthcare systems.
Traditional AAT
EXPERIMENTALStaff in clinics randomized to this arm will also receive Announcement Approach Training (AAT). The training will be organized and delivered by outside experts.
Interventions
AAT is a one-hour communication workshop that trains clinical staff how to recommend HPV vaccine for children ages 9-12. In the champion arm, vaccine champions will deliver the training using slides and a standardized script. They will also conduct outreach and sustainability planning.
AAT is a one-hour communication workshop that trains clinical staff how to recommend HPV vaccine for children ages 9-12. In the traditional arm, outside experts will deliver the training using the same slides and script.
Eligibility Criteria
You may qualify if:
- Clinics are eligible if they:
- provide primary care to children ages 9-12
- specialize in pediatrics or family medicine
- Children's medical records will be eligible to be included in the dataset if children:
- are between the ages of 9-12 years at baseline
- are attributed to a participating clinic at 12-month follow-up
You may not qualify if:
- Clinics are excluded if they:
- do not provide primary care to children ages 9-12
- have a specialty other than pediatrics or family medicine
- Children's medical records will be excluded if children:
- are not between the ages of 9-12 years at baseline
- are not attributed to a participating clinic at 12-month follow-up
- are receiving hospice/palliative care, are pregnant, or have a history of HPV vaccine contraindications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UNC Lineberger Comprehensive Cancer Centerlead
- National Cancer Institute (NCI)collaborator
- University of Wisconsin, Madisoncollaborator
Study Sites (2)
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
University of Wisconsin - Madison
Madison, Wisconsin, 53726, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Noel T Brewer, PhD
University of North Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2023
First Posted
February 21, 2023
Study Start
March 8, 2023
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
March 9, 2026
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share